Explore
Validate
Learn
ImmunocytochemistryAntibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- HPA001912 - Provider product page
- Provider
- Atlas Antibodies
- Proper citation
- Atlas Antibodies Cat#HPA001912, RRID:AB_1080251
- Product name
- Anti-TFAP4
- Antibody type
- Polyclonal
- Description
- Polyclonal Antibody against Human TFAP4, Gene description: transcription factor AP-4 (activating enhancer binding protein 4), Alternative Gene Names: AP-4, bHLHc41, Validated applications: IHC, ICC, Uniprot ID: Q01664, Storage: Store at +4°C for short term storage. Long time storage is recommended at -20°C.
- Reactivity
- Human
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 100 µl
- Concentration
- 0.2 mg/ml
- Storage
- Store at +4°C for short term storage. Long time storage is recommended at -20°C.
- Handling
- The antibody solution should be gently mixed before use.
Submitted references Soluble Heparin Binding Epidermal Growth Factor-Like Growth Factor Is a Regulator of GALGT2 Expression and GALGT2-Dependent Muscle and Neuromuscular Phenotypes
Inhibitory effect of CC chemokine ligand 23 (CCL23)/ transcription factor activating enhancer binding protein 4 (TFAP4) on cell proliferation, invasion and angiogenesis in hepatocellular carcinoma
Modulation of transcription factor binding and epigenetic regulation of the MLH1 CpG island and shore by polymorphism rs1800734 in colorectal cancer
MYCN promotes neuroblastoma malignancy by establishing a regulatory circuit with transcription factor AP4
AP4 is a mediator of epithelial–mesenchymal transition and metastasis in colorectal cancer
Cramer M, Xu R, Martin P
Molecular and Cellular Biology 2023;39(14)
Molecular and Cellular Biology 2023;39(14)
Inhibitory effect of CC chemokine ligand 23 (CCL23)/ transcription factor activating enhancer binding protein 4 (TFAP4) on cell proliferation, invasion and angiogenesis in hepatocellular carcinoma
Wang W, Wu J, Dai X, Cheng K
Bioengineered 2022;13(1):1626-1636
Bioengineered 2022;13(1):1626-1636
Modulation of transcription factor binding and epigenetic regulation of the MLH1 CpG island and shore by polymorphism rs1800734 in colorectal cancer
Savio A, Bapat B
Epigenetics 2017;12(6):441-448
Epigenetics 2017;12(6):441-448
MYCN promotes neuroblastoma malignancy by establishing a regulatory circuit with transcription factor AP4
Xue C, Yu D, Gherardi S, Koach J, Milazzo G, Gamble L, Liu B, Valli E, Russell A, London W, Liu T, Cheung B, Marshall G, Perini G, Haber M, Norris M
Oncotarget 2016;7(34):54937-54951
Oncotarget 2016;7(34):54937-54951
AP4 is a mediator of epithelial–mesenchymal transition and metastasis in colorectal cancer
Jackstadt R, Röh S, Neumann J, Jung P, Hoffmann R, Horst D, Berens C, Bornkamm G, Kirchner T, Menssen A, Hermeking H
Journal of Experimental Medicine 2013;210(7):1331-1350
Journal of Experimental Medicine 2013;210(7):1331-1350
No comments: Submit comment
No validations: Submit validation data